CP-675,206

· AstraZeneca

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for CP-675,206, covering 2012-06-06 to 2020-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma [Phase 2]